Primary Liver Cancer Cohort of South China

Launched by HUILIAN ZHU · Sep 27, 2017

Keywords

ClinConnect Summary

This clinical trial is examining important factors that affect the occurrence and long-term survival of patients with primary liver cancer. Researchers will collect detailed medical information about participants, such as the stage of cancer and liver function scores, to better understand how these factors influence treatment outcomes. The study will follow participants for up to two years after their therapy to track important results like recurrence of cancer or any spread to other parts of the body.

To be eligible for this study, participants should be between 18 and 80 years old and must have been recently diagnosed with primary liver cancer without having received any treatment yet. They should also not have multiple types of cancer at the same time. Those who join can expect regular check-ins every two years to monitor their health and cancer status. This trial aims to improve knowledge about liver cancer and ultimately enhance patient care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • age 18-80 years
• • consistent with primary liver cancer diagnostic criteria
• • first diagnosis (from diagnosis to admission interval of less than a month)
• • did not do any treatment of liver cancer
• Exclusion Criteria:
• • refused to participate in this study
• • suffering from more than two kinds of primary tumors